Conference report by Simon Collins, HIV i-Base
A retrospective study reported high recent use of GLP-1 receptor agonists in people living with HIV at a UK centre, with results unexpectedly including viral rebound in 18%.
The study identified 65 participants from the pharmacy database at the University Hospitals of Leicester HIV service between January 2024 and March 2026, based on prescribed or disclosed use of GLP-1 agonists.
Read the full report here.
Source : HIV i-Base
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.